ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
6,051.09
0.00%
Dow Jones
43,828.06
-0.20%
US Dollar vs MXN
20.1304
0.00%
Brent Oil
74.135
0.00%
Bitcoin
101,138.79
-0.31%
Pepperstone
Advertisement
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Nkarta Inc (NKTX)

  7. Nkarta Inc (NKTX) Noticias

NKTX

Nkarta (NKTX)

Nkarta Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:NKTX
FechaHoraFuenteTítuloSímboloCompañía
05/12/202405:01GlobeNewswire Inc.Nkarta Announces IND Clearance of Investigator-Sponsored Trial in Myasthenia Gravis and Opening of Enrollment for Ntrust-2NASDAQ:NKTXNkarta Inc
26/11/202406:02GlobeNewswire Inc.Nkarta to Participate in an Upcoming Investor ConferenceNASDAQ:NKTXNkarta Inc
14/11/202415:05Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:NKTXNkarta Inc
08/11/202413:17Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:NKTXNkarta Inc
07/11/202415:21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NKTXNkarta Inc
07/11/202415:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NKTXNkarta Inc
07/11/202415:02GlobeNewswire Inc.Nkarta Reports Third Quarter 2024 Financial Results and Corporate HighlightsNASDAQ:NKTXNkarta Inc
03/09/202415:01GlobeNewswire Inc.Nkarta to Participate in Upcoming Investor ConferenceNASDAQ:NKTXNkarta Inc
23/08/202415:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
13/08/202420:03GlobeNewswire Inc.Correction: Nkarta Reports Second Quarter 2024 Financial Results and Corporate HighlightsNASDAQ:NKTXNkarta Inc
13/08/202415:01GlobeNewswire Inc.Nkarta Reports Second Quarter 2024 Financial Results and Corporate HighlightsNASDAQ:NKTXNkarta Inc
31/07/202415:47Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
24/07/202405:00GlobeNewswire Inc.Nkarta Announces Initiation of Investigator-Sponsored Clinical Trial Evaluating NKX019 for Systemic Lupus ErythematosusNASDAQ:NKTXNkarta Inc
16/07/202405:01GlobeNewswire Inc.Nkarta Announces Leadership Updates, Appoints Nadir Mahmood as PresidentNASDAQ:NKTXNkarta Inc
27/06/202405:00GlobeNewswire Inc.Nkarta Initiates Clinical Trial of NKX019 in Lupus Nephritis with First Patient in Screening and Announces Pipeline Expansion to Additional Autoimmune IndicationsNASDAQ:NKTXNkarta Inc
13/06/202415:01GlobeNewswire Inc.Nkarta Adds Experienced Leader in Autoimmune R&D, George Vratsanos, M.D., FACR, to Board of DirectorsNASDAQ:NKTXNkarta Inc
09/05/202415:01GlobeNewswire Inc.Nkarta Reports First Quarter 2024 Financial Results and Corporate HighlightsNASDAQ:NKTXNkarta Inc
03/04/202415:02GlobeNewswire Inc.Nkarta to Participate in Upcoming Investor ConferencesNASDAQ:NKTXNkarta Inc
25/03/202405:30GlobeNewswire Inc.Nkarta Announces Pricing of $240 Million Underwritten OfferingNASDAQ:NKTXNkarta Inc
21/03/202415:01GlobeNewswire Inc.Nkarta Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate HighlightsNASDAQ:NKTXNkarta Inc
01/03/202415:32Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NKTXNkarta Inc
09/02/202405:38Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:NKTXNkarta Inc
03/01/202415:15Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:NKTXNkarta Inc
09/12/202319:31GlobeNewswire Inc.Nkarta Presents NKX101 Clinical Data at the 2023 American Society of Hematology Annual Meeting & ExpositionNASDAQ:NKTXNkarta Inc
13/11/202307:25Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:NKTXNkarta Inc
09/11/202315:02GlobeNewswire Inc.Nkarta Reports Third Quarter 2023 Financial Results and Corporate HighlightsNASDAQ:NKTXNkarta Inc
07/11/202307:02GlobeNewswire Inc.Nkarta to Participate at Upcoming Investor ConferencesNASDAQ:NKTXNkarta Inc
27/10/202315:05Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:NKTXNkarta Inc
17/10/202311:00Dow Jones NewsNkarta's Stock Climbs 28% After FDA Approves Drug ApplicationNASDAQ:NKTXNkarta Inc
17/10/202310:47PR Newswire (US)Lupus Therapeutics Announces Partnership to Support the Evaluation of Natural Killer (NK) Cell Therapy in Lupus NephritisNASDAQ:NKTXNkarta Inc
 Showing the most relevant articles for your search:NASDAQ:NKTX

Su Consulta Reciente

USOTC
BASFY
BASF (QX)
NASDAQ
GOOGL
Alphabet
CCOM
SILVER
SILVER
SPI
SP500
S&P 500
NASDAQ
AAPL
Apple
AMEX
XLF
Financial Select Sector
NASDAQ
TSLA
Tesla
USOTC
DTEGY
Deutsche Telekom (QX)
COIN
XRPUSD
Ripple
COIN
ADAUSD
Cardano
NYSE
XOM
Exxon Mobil
NYSE
KO
Coca Cola
NASDAQ
QQQ
Invesco QQQ Trust Series 1
AMEX
XLE
Energy Select Sector SPDR
CCOM
US500
US 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados